Research Article

Achieving Universal Access for Human Immunodeficiency Virus and Tuberculosis: Potential Prevention Impact of an Integrated Multi-Disease Prevention Campaign in Kenya

Table 1

CD 4 values from the campaign, hospital reference, and KAIS data sets. The table gives N, the number of people for whom a CD4 cell count was done, the median CD4 cell count, and the proportion of those tested that are below 250, 350, and 500 cells/μL. Numbers in brackets are percentages. Using a Kolmogorov-Smirnov test, The CD4 cell count distribution for the Hospital Reference data set is significantly different from the other two ( in both cases) but the Campaign and KAIS data sets are not significantly different ( ).

CampaignHospital referenceNyanza KAIS

N2551284306

Median/μL536348550
33 (13%)436 (34%)52 (17%)
64 (25%)642 (50%)92 (30%)
112 (44%)899 (70%)141 (46%)

187 (74%)1137 (89%)220 (72%)

228 (90%)1215 (95%)258 (84%)